5-(4-Hydroxy-2,3,5-trimethylbenzylidene) thiazolidine-2,4-dione attenuates atherosclerosis possibly by reducing monocyte recruitment to the lesion

A variety of benzylidenethiazole analogs have been demonstrated to inhibit 5-lipoxygenase (5-LOX). Here we report the anti-atherogenic potential of 5-(4-hydroxy-2,3,5-trimethylbenzylidene) thiazolidin-2,4-dione (HMB-TZD), a benzylidenethiazole analog, and its potential mechanism of action in LDL rec...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Choi, Jae-Hoon, Park, Jong-Gil, Jeon, Hyung Jun, Kim, Mi-Sun, Lee, Mi-Ran, Lee, Mi-Ni, Sonn, SeongKeun, Kim, Jae-Hong, Lee, Mun Han, Choi, Myung-Sook, Park, Yong Bok, Kwon, Oh-Seung, Jeong, Tae-Sook, Lee, Woo Song, Shim, Hyun Bo, Shin, Dong Hae, Oh, Goo Taeg
Formato: Artigo
Idioma:Inglês
Publicado em: Korean Society for Biochemistry and Molecular Biology 2011
Assuntos:
Original Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3174381/
https://ncbi.nlm.nih.gov/pubmed/21691142
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3858/emm.2011.43.8.053
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados